Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 49Central Nervous System Neoplasms 46Medulloblastoma 26Brain Neoplasms 23Astrocytoma 23Sarcoma 15Testicular Neoplasms 14Oligodendroglioma 13Familial ependymoma 13Ovarian Neoplasms 12Glioblastoma 12Testicular Germ Cell Tumor 11Lymphoma 11Neuroectodermal Tumors, Primitive, Peripheral 10Wilms Tumor 9Optic Nerve Glioma 9Gliosarcoma 9Ependymoma 9Choroid Plexus Neoplasms 9Rhabdoid Tumor 8Retinoblastoma 8Glioma 8Teratoma 7Kidney Neoplasms 7Osteosarcoma 6Head and Neck Neoplasms 6Burkitt Lymphoma 6Recurrence 5Neuroectodermal Tumors, Primitive 5Esthesioneuroblastoma, Olfactory 5

Interventions

Cyclophosphamide 8dinutuximab 7Magnetic Resonance Spectroscopy 7Topotecan 6Doxorubicin 6sargramostim 5Vincristine 5Stem Cell Transplantation 5Radiation 5Platinum 5Melphalan 5Isotretinoin 5Colony-Stimulating Factors 5Cisplatin 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Temozolomide 4Specimen Handling 4Irinotecan 4Etoposide 4Congresses as Topic 4Carboplatin 4Thiotepa 3Busulfan 33-Iodobenzylguanidine 3etoposide phosphate 2Razoxane 2Dexrazoxane 2temsirolimus 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Filgrastim × CNS × Clear all
NCT01798004 2024-07-15

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Children's Oncology Group

Phase 1 Completed
150 enrolled 9 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡